Delivery Order SPE2DB22D2007-SPE2DB25FJ0WW

Award Date 4/22/25
Potential Completion Date 5/13/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,027.00 Delivery Order contract is for the supply of Albumin (Human) 25% IV Solution, a critical medical product, with a completion date of November 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,040.20, is for the delivery of Albumin (Human) 25% IV Solution 50ML and has an ultimate completion date of April 28, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,552.78, is for the delivery of 100 ml bottles of 25% Albumin (Human) Intravenous Solution. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $2,260.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Albumin (Human) 5% IV Solution in 250 mL packages, with a period of performance through December 13, 2024. The contract is a Firm Fixed Price Delivery Order and was not designated as a set-aside. In addition to this specific award, AmerisourceBergen holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $20,547.76, is for the delivery of Albumin (Human) 25% IV Solution 100 mL. This is a firm fixed-price delivery order contract with an ultimate completion date of August 16, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,109.70 for the supply of Albumin (Human) 5% IV Solution 250ML to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of July 18, 2024 and was awarded on June 26, 2024 as a Firm Fixed Price contract. Amerisourcebergen is a major pharmaceutical distribution company that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Albumin (Human) 5% IV Solution 250 ML, a critical medical commodity. The contract has a ceiling value of $1,255.80 and a completion date of February 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA,...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Albumin (Human) 5% IV Solution 250ML. The delivery order has a ceiling value of $3,139.50 and a performance period extending through May 29, 2025. This order is placed under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is a $999,999,999.00 prime contract that provides a comprehensive global pharmaceutical support vehicle....
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Albumin (Human) 5% IV Solution 250ML, a medical product, with a ceiling value of $2,511.60 and a completion date of June 10, 2025. The contract is firm fixed price and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award, with ID SPE2DB20D3101|SPE2DB25FRER3, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 25% Albumin (Human) IV Solution in 100 mL containers, a critical medical commodity for government healthcare programs. The contract has a ceiling value of $1,040.10 and is a Firm Fixed Price Delivery Order, valid through April 7, 2025. The contract is not designated with any set-aside...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ0WW
    Delivery Order

This federal contract award, valued at $1,040.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Albumin (Human) 25% IV Solution, a critical medical product, with a performance period extending through May 13, 2025.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The current delivery order is not designated as a set-aside contract, indicating open competition.

Generated 7/22/25, 10:00 AM